Innovation around DED’s

Innovation for DED’s

It is critically important that advances in AI technology are included in the screening procedure for DEDs to support our goal of improving access to care for underserved and at-risk populations. Technology can help to improve the accuracy and efficiency of the screening process for all DEDs, especially diabetes-related retinopathy which affects 463 million people worldwide 73. Improvements in screening technology will also benefit ophthalmologists and retinal specialists by reducing their workload and ensuring patients get quick and reliable diagnoses so as to best manage their condition.


Access the full bibliography here:

Newsletter Signup

To keep up to date with our news and activities,
please leave your details below

GDPR Compliance Please indicate your consent for Retina International to contact you via the email address listed for the purposes of general alerts and newsletters.